Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5OIO

InhA (T2A mutant) complexed with 5-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-N-ethyl-1,3,4-thiadiazol-2-amine

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-E+ SUPERBRIGHT
Temperature [K]100
Detector technologyCCD
Collection date2015-09-15
DetectorRIGAKU SATURN A200
Wavelength(s)1.54
Spacegroup nameI 21 21 21
Unit cell lengths91.390, 99.490, 185.670
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution29.480 - 2.740
R-factor0.159
Rwork0.157
R-free0.20100
RMSD bond length0.010
RMSD bond angle1.120
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]92.8403.870
High resolution limit [Å]2.7402.740
Rmerge0.1120.171
Number of reflections2208914355
<I/σ(I)>12.48.1
Completeness [%]97.999.1
Redundancy2.82.8
CC(1/2)0.9260.843
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP29335-42% Ethoxyethanol and 0.1M Mes pH 6.5-6.8. 5% glycerol used as cryoprotectant. Crystals were soaked to obtain ligand complex.

219140

PDB entries from 2024-05-01

PDB statisticsPDBj update infoContact PDBjnumon